Arena Group Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Arena Group Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $16.89M | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | $13.25M | Mar 31, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.83M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $125.91M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $143.63M | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | $26.82M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $189.14M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $128.03M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $53.34M | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | $7.59M | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $5.77M | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $6.27M | Apr 9, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $77.0K | May 15, 2018 |
| FY2017 | Dec 31, 2016 | $0 | May 15, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.35M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $55.72M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $55.27M | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | $3.80M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $78.61M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $24.97M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $6.04M | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | ($26.6K) | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $283.1K | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $621.4K | Apr 9, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $124.86M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($100.71M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | ($55.58M) | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | ($3.47M) | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | ($89.94M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($89.23M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($38.50M) | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | ($19.68M) | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | ($10.59M) | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | ($8.93M) | Apr 9, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.79M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $7.87M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | ($17.46M) | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | ($3.53M) | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | ($84.28M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($71.19M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($40.81M) | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | ($9.70M) | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | ($7.15M) | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | ($4.86M) | Apr 9, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $1.18M | Jan 8, 2021 |
| FY2018 | Dec 31, 2017 | $114.9K | Jan 8, 2021 |
| FY2017 | Dec 31, 2016 | $411.7K | May 15, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.25M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($16.08M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | ($24.77M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($11.30M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($14.73M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($32.29M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($56.95M) | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | ($52.75M) | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | ($47.08M) | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | ($1.20M) | Apr 9, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $54.0K | Mar 16, 2026 |
| FY2023 | Dec 31, 2022 | $530.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $377.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.21M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $150.8K | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | $77.2K | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $25.4K | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $3.6K | Apr 9, 2021 |
| FY2019 | Dec 31, 2018 | $31.6K | Apr 9, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.60M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $116.35M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $188.88M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $203.72M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $173.98M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $214.20M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $196.99M | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | $104.15M | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $112.59M | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $33.53M | Apr 9, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $117.43M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $246.51M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $247.71M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $242.69M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $211.77M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $216.10M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $178.41M | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | $107.50M | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $100.41M | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $33.48M | Apr 9, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.83M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($130.33M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | ($59.00M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | ($52.15M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | ($51.68M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | ($20.31M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($37.07M) | Apr 1, 2022 |
| FY2019 | Sep 30, 2019 | ($41.32M) | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | ($25.78M) | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | ($18.17M) | Apr 9, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.58M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $42.58M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $42.58M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $39.34M | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | $19.62M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $16.14M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $16.14M | Apr 1, 2022 |
| FY2019 | Sep 30, 2019 | $16.14M | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $7.32M | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $7.32M | Apr 9, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($354.51M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($479.36M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | ($378.65M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($323.07M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($252.21M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($162.27M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($73.04M) | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | ($73.74M) | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | ($54.06M) | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | ($43.47M) | Apr 9, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.34M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $4.36M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $9.28M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $13.87M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $9.35M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.03M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $8.85M | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | $1.97M | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $13.15M | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $2.14M | Apr 9, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.58M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $110.44M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $102.31M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $65.68M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $70.12M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $62.19M | Apr 1, 2022 |
| FY2019 | Dec 31, 2019 | $31.18M | Apr 9, 2021 |
| FY2019 | Sep 30, 2019 | $252.5K | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | $252.5K | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | $252.5K | Apr 9, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (4) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | (7) | Mar 31, 2023 |
| FY2015 | Dec 31, 2015 | 0 | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (4) | Apr 1, 2024 |
| FY2015 | Dec 31, 2015 | 0 | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Mar 28, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.59M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 47.56M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | 23.84M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 18.30M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 12.64M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 10.41M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | 37.12M | Aug 16, 2021 |
| FY2019 | Sep 30, 2019 | 37.35M | Apr 9, 2021 |
| FY2019 | Jun 30, 2019 | 36.94M | Apr 9, 2021 |
| FY2019 | Mar 31, 2019 | 37.69M | Apr 9, 2021 |